Soft Tissue Sarcoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma Intervention: Drug: pembrolizumab, pazopanib Sponsor: Yonsei University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2023 Category: Research Source Type: clinical trials
